LAN; Ping
Patent Applications and Registrations
Patent applications and USPTO patent grants for LAN; Ping.The latest application filed is for "display panel and display device".
- LAN; Ping - Langfang CN
- Lan; Ping - Plainsboro NJ
- LAN; Ping - Kenilworth NJ US
- Lan; Ping - Dayton NJ
- Lan; Ping - Nanjing CN
| Patent | Date |
|---|---|
| Display Panel And Display Device App 20220270529 - LAN; Ping ; et al. | 2022-08-25 |
| Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists Grant 11,161,819 - Adams , et al. November 2, 2 | 2021-11-02 |
| Factor XIIa inhibitors Grant 10,875,851 - Rao , et al. December 29, 2 | 2020-12-29 |
| Hydroxy isoxazole compounds useful as GPR120 agonists Grant 10,864,211 - Debenham , et al. December 15, 2 | 2020-12-15 |
| Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists App 20200347020 - Adams; Gregory L. ; et al. | 2020-11-05 |
| Factor XIIa Inhibitors App 20190352294 - Rao; Ashwin U. ; et al. | 2019-11-21 |
| Hydroxy Isoxazole Compounds Useful As Gpr120 Agonists App 20190269679 - Debenham; John S. ; et al. | 2019-09-05 |
| Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists App 20190161448 - Adams; Gregory L. ; et al. | 2019-05-30 |
| Substituted spiropiperidinyl compounds useful as GPR120 agonists Grant 9,708,270 - Chelliah , et al. July 18, 2 | 2017-07-18 |
| Mineralocorticoid receptor antagonists Grant 9,487,506 - Lan , et al. November 8, 2 | 2016-11-08 |
| Mineralocorticoid receptor antagonists Grant 9,403,807 - Crespo , et al. August 2, 2 | 2016-08-02 |
| Transgenic Plants With Increased Trace Element Contents And Methods For Producing The Same App 20150315250 - Schmidt; Wolfgang ; et al. | 2015-11-05 |
| Mineralocorticoid Receptor Antagonists App 20150284376 - Crespo; Alejandro ; et al. | 2015-10-08 |
| Substituted Spiropiperidinyl Compounds Useful As Gpr120 Agonists App 20150274672 - Chelliah; Mariappan ; et al. | 2015-10-01 |
| Mineralocorticoid receptor antagonists Grant 8,933,113 - Crespo , et al. January 13, 2 | 2015-01-13 |
| Mineralocorticoid Receptor Antagonists App 20140336224 - Lan; Ping ; et al. | 2014-11-13 |
| Mineralocorticoid Receptor Antagonists App 20130331419 - Crespo; Alejandro ; et al. | 2013-12-12 |
| Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,563,746 - Dang , et al. October 22, 2 | 2013-10-22 |
| Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,410,284 - Dang , et al. April 2, 2 | 2013-04-02 |
| Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,394,969 - Bookser , et al. March 12, 2 | 2013-03-12 |
| Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,329,914 - Bao , et al. December 11, 2 | 2012-12-11 |
| Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110263533 - Dang; Qun ; et al. | 2011-10-27 |
| Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110218174 - Bao; Jianming ; et al. | 2011-09-08 |
| Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110195964 - Dang; Qun ; et al. | 2011-08-11 |
| Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20100081643 - BOOKSER; BRETT C. ; et al. | 2010-04-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 